BCM
DVAX

BluePath Capital Management’s Dynavax Technologies DVAX Stock Holding History

BluePath Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,239
Closed -$33.1K – 167
2023
Q3 		$33.1K Buy
+2,239
New +$31.5K 0.03% 240

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BluePath Capital Management's DVAX Position: Q4 2023 in Review

BluePath Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2023, closing a stake of 2,239 shares — an estimated $33.1K sold.

BluePath Capital Management first reported a position in DVAX in Q3 2023 and held it in 1 quarter. The position peaked at $33.1K in Q3 2023. 246 funds tracked by Wall St. Rank hold DVAX as of Q4 2023.

  • BluePath Capital Management reported no remaining Dynavax Technologies position as of Q4 2023 after selling out during the quarter.
  • BluePath Capital Management sold 2,239 Dynavax Technologies shares in Q4 2023, an estimated $33.1K.
  • BluePath Capital Management first reported a position in Dynavax Technologies in Q3 2023 and held it in 1 quarter.
  • BluePath Capital Management's Dynavax Technologies position peaked at $33.1K in Q3 2023.
  • 246 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2023.

Based on BluePath Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.